Greenbrook Mental Wellness Centers
Mental health clinic in Anchorage, Alaska.
No reviews yet
View DetailsSpravato (Esketamine) in Anchorage, Alaska
Compare 2 Spravato (Esketamine) clinics in Anchorage, Alaska that offer care for treatment-resistant depression and major depressive disorder. Review services, ratings, and contact details to find the right provider near you.
Clinics
2 clinics shown
Wisdom Traditions Counseling Services LLC
Wisdom Traditions Counseling Services operates an outpatient mental health practice in Anchorage near the International Airport Road corridor, providing counseling and addiction treatment services. The practice addresses substance use disorders alongside general mental health concerns for adults seeking behavioral health support. Specific treatment modalities such as TMS, esketamine, or ketamine therapy are not listed in available information; prospective patients should inquire directly about available therapeutic approaches and whether specialized depression treatments are offered.
No reviews yetView Details
About Spravato (Esketamine)
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.